Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adc Therapeutics Sa (NY: ADCT )

4.630 -0.270 (-5.51%)
Official Closing Price Updated: 7:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 510,139
Open 5.050
Bid (Size) 4.520 (1)
Ask (Size) 4.890 (9)
Prev. Close 4.900
Today's Range 4.600 - 5.050
52wk Range 2.690 - 17.89
Shares Outstanding 76,721,543
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder
From ADC Therapeutics SA
Via Business Wire
ADC Therapeutics to Participate in February Investor Conferences
From ADC Therapeutics SA
Via Business Wire

Performance

YTD
+28.97%
+28.97%
1 Month
+33.05%
+33.05%
3 Month
+8.69%
+8.69%
6 Month
-42.48%
-42.48%
1 Year
-71.30%
-71.30%

More News

Read More
The Latest Analyst Ratings for ADC Therapeutics
Via Benzinga
Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
Via Benzinga
4 Analysts Have This to Say About ADC Therapeutics
Via Benzinga
Analyst Ratings for ADC Therapeutics
Via Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From ADC Therapeutics SA
Via Business Wire
ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer
From ADC Therapeutics SA
Via Business Wire
Nike, FedEx And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
Via Benzinga
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
From ADC Therapeutics SA
Via Business Wire
ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer
From ADC Therapeutics SA
Via Business Wire
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
Via Talk Markets
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
Via Benzinga
ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From ADC Therapeutics SA
Via Business Wire
ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
From ADC Therapeutics SA
Via Business Wire
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting
From ADC Therapeutics SA
Via Business Wire
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
From ADC Therapeutics SA
Via Business Wire
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
From IGM Biosciences, Inc.
Via Globe NewsWire
ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer
From ADC Therapeutics SA
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.